Rapport Therapeutics, Inc. RAPP Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s other operating expenses?
- Rapport Therapeutics, Inc. (RAPP) reported other operating expenses of $44.22M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s other operating expenses changed year-over-year?
- Rapport Therapeutics, Inc.'s other operating expenses increased by 63.1% year-over-year, from $27.11M to $44.22M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s other operating expenses?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s other operating expenses has grown at a 86.0% compound annual growth rate (CAGR), from $36.18M to $125.1M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.